Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
919.7 DKK | 0.00% | -0.68% | +31.92% |
12:00pm | Weight-loss drug forecasts jump to $150 billion as supply grows | RE |
11:36am | NOVO NORDISK : Deutsche Bank reaffirms its Buy rating | ZD |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.92% | 594B | |
+38.51% | 727B | |
-6.23% | 354B | |
+18.78% | 328B | |
+1.35% | 277B | |
+15.00% | 243B | |
+7.89% | 205B | |
-5.77% | 203B | |
+6.19% | 164B | |
+0.31% | 164B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- Lars Fruergaard Jorgensen, CEO of Novo Nordisk: dose limitation to continue until 2024